NO20044700L - Ny assoiasjon av et antitrombotisk middel og aspirin - Google Patents

Ny assoiasjon av et antitrombotisk middel og aspirin

Info

Publication number
NO20044700L
NO20044700L NO20044700A NO20044700A NO20044700L NO 20044700 L NO20044700 L NO 20044700L NO 20044700 A NO20044700 A NO 20044700A NO 20044700 A NO20044700 A NO 20044700A NO 20044700 L NO20044700 L NO 20044700L
Authority
NO
Norway
Prior art keywords
aspirin
antithrombotic agent
new association
association
new
Prior art date
Application number
NO20044700A
Other languages
English (en)
Norwegian (no)
Inventor
Gilbert Lavielle
Tony Verbeuren
Marie-Odile Vallez
Bernard Cimetiere
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20044700L publication Critical patent/NO20044700L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20044700A 2002-04-05 2004-10-29 Ny assoiasjon av et antitrombotisk middel og aspirin NO20044700L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0204222A FR2838057B1 (fr) 2002-04-05 2002-04-05 Nouvelle association d'un antithrombotique et d'aspirine
PCT/FR2003/001054 WO2003084525A1 (fr) 2002-04-05 2003-04-04 Nouvelle association d'un antithrombotique et d'aspirine

Publications (1)

Publication Number Publication Date
NO20044700L true NO20044700L (no) 2004-10-29

Family

ID=28052120

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044700A NO20044700L (no) 2002-04-05 2004-10-29 Ny assoiasjon av et antitrombotisk middel og aspirin

Country Status (26)

Country Link
US (1) US7618955B2 (enExample)
EP (1) EP1496884B1 (enExample)
JP (1) JP4065853B2 (enExample)
KR (1) KR100645143B1 (enExample)
CN (1) CN1297265C (enExample)
AR (1) AR039253A1 (enExample)
AT (1) ATE329591T1 (enExample)
AU (1) AU2003246774B2 (enExample)
BR (1) BR0309019A (enExample)
CA (1) CA2480697A1 (enExample)
CY (1) CY1105106T1 (enExample)
DE (1) DE60306133T2 (enExample)
DK (1) DK1496884T3 (enExample)
EA (1) EA006978B1 (enExample)
ES (1) ES2264533T3 (enExample)
FR (1) FR2838057B1 (enExample)
GE (1) GEP20074101B (enExample)
MA (1) MA27114A1 (enExample)
MX (1) MXPA04009760A (enExample)
NO (1) NO20044700L (enExample)
NZ (1) NZ535430A (enExample)
PL (1) PL371620A1 (enExample)
PT (1) PT1496884E (enExample)
UA (1) UA79457C2 (enExample)
WO (1) WO2003084525A1 (enExample)
ZA (1) ZA200407593B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SMP200800012B (it) * 2005-07-22 2008-02-27 Procter & Gamble Composizioni per ridurre l'incidenza di aritmia indotta da farmaco
CN103071154A (zh) 2007-04-13 2013-05-01 千年药品公司 用起因子xa抑制剂作用的化合物的组合抗凝治疗
JP2009001537A (ja) * 2007-06-25 2009-01-08 Lab Servier 血管障害の処置を目的とする医薬の入手における抗アテローム血栓化合物の使用
FR2920772B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
US7618955B2 (en) 2009-11-17
UA79457C2 (en) 2007-06-25
EP1496884A1 (fr) 2005-01-19
NZ535430A (en) 2006-09-29
CN1297265C (zh) 2007-01-31
FR2838057A1 (fr) 2003-10-10
BR0309019A (pt) 2005-02-01
FR2838057B1 (fr) 2005-07-08
MA27114A1 (fr) 2004-12-20
DK1496884T3 (da) 2006-10-02
EA006978B1 (ru) 2006-06-30
ATE329591T1 (de) 2006-07-15
CY1105106T1 (el) 2009-11-04
PL371620A1 (en) 2005-06-27
ES2264533T3 (es) 2007-01-01
EP1496884B1 (fr) 2006-06-14
EA200401293A1 (ru) 2005-02-24
AU2003246774A1 (en) 2003-10-20
MXPA04009760A (es) 2004-12-13
AR039253A1 (es) 2005-02-16
GEP20074101B (en) 2007-05-10
HK1076034A1 (en) 2006-01-06
WO2003084525A1 (fr) 2003-10-16
ZA200407593B (en) 2006-07-26
AU2003246774B2 (en) 2007-02-15
PT1496884E (pt) 2006-09-29
JP2005528376A (ja) 2005-09-22
DE60306133T2 (de) 2007-01-04
US20050143354A1 (en) 2005-06-30
KR100645143B1 (ko) 2006-11-10
KR20040098053A (ko) 2004-11-18
DE60306133D1 (de) 2006-07-27
CN1646111A (zh) 2005-07-27
CA2480697A1 (fr) 2003-10-16
JP4065853B2 (ja) 2008-03-26

Similar Documents

Publication Publication Date Title
DE60225040D1 (de) Montelukast-granulatformulierung
NO962187D0 (no) Sammensetninger som inhiberer apoptose, fremgangsmåter for rensing av sammensetningene og anvendelse derav
IS7735A (is) Bensódíasepín afleiður og lyfjasamsetningar sem innihalda þær.
EE05074B1 (et) Sulfoonamiid- ja sulfamiidasendatud imidasokinoliinid, nende kasutamine raviks ja neid sisaldavad farmatseutilised preparaadid
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
LTPA2018502I1 (lt) Per burną vartojamos kladribino kompozicijos
DK0994710T3 (da) Farmaceutiske præparater til oral indgivelse omfattende en benzhydrylpiperazin og en cyclodextrin
TNSN04206A1 (en) Novel perindopril salt and pharmaceutical compositions containing same
DE69840603D1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
ATE409065T1 (de) Inhibitoren der 17 beta- hydroxysteroiddehydrogenase des typs 3 zur behandlung androgenabhängiger krankheiten
SE0101932D0 (sv) Pharmaceutical combinations
HUP0301991A2 (hu) IL-18-inhibitorok alkalmazása atheroszklerózis kezelésére és/vagy megelżzésére
DK1404304T3 (da) Tablet omfattende cetirizin og pseudoephedrin
ATE282607T1 (de) Tryptase-inhibitoren
BR0314129A (pt) Formulações de liberação modificadas de oxcarbazepina e derivados destas
CR7198A (es) Tableta que contiene cetirizina y pseudoefedrina
DK1355906T3 (da) 2H-1-benzopyranderivater, fremgangsmåder til deres fremstilling og farmaceutiske sammensætninger indeholdende dem
NO20044700L (no) Ny assoiasjon av et antitrombotisk middel og aspirin
ATE305517T1 (de) Neurotrypsin
HRP20050611A2 (en) Combination medicament
NO20054346L (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander
NO20065903L (no) Ny assosiasjon av en sinusknute If strominhibitor og en kalsiuminhibitor, og farmasoytiske sammensetninger inneholdende den
NO20061944L (no) Ny assosiasjon av et antiaterotrombotisk middel og et antiplateaggregerede middel
DE60322577D1 (de) Tablette enthaltend efletirizin und pseudoephedrin
DK1490049T3 (da) Citalopram til behandling af forhöjet blodtryk

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application